← Browse by Condition
Medical Condition
subarachnoid hemorrhage
Total Trials
8
Recruiting Now
8
Trial Phases
Various
ClinicalMetric tracks all active clinical trials for subarachnoid hemorrhage sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — subarachnoid hemorrhage Clinical Trials
How many clinical trials are currently recruiting for subarachnoid hemorrhage?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for subarachnoid hemorrhage, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for subarachnoid hemorrhage?
subarachnoid hemorrhage research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a subarachnoid hemorrhage clinical trial?
Eligibility criteria for subarachnoid hemorrhage trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT03318432
Recruiting
Stroke Recovery Initiative - Registry for Stroke Research Studies
Enrollment
60,000 pts
Location
United States
Sponsor
University of California, San ...
NCT05777499
Recruiting
MUSic Therapy In Complex Specialist Neurorehabilitation
Enrollment
75 pts
Location
United Kingdom
Sponsor
University College, London
NCT06724029
Recruiting
Neurosurgical Outcome Network
Enrollment
4,500 pts
Location
Italy
Sponsor
Fondazione I.R.C.C.S. Istituto...
NCT03245866
Recruiting
Swiss Study on Subarachnoid Hemorrhage
Enrollment
5,000 pts
Location
Switzerland
Sponsor
University Hospital, Geneva
NCT05649904
Recruiting
AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis
Enrollment
240 pts
Location
United States
Sponsor
Ohio State University
NCT04490161
Recruiting
Prevention of Vasospasm in SAH Through CSF Treatment
Enrollment
20 pts
Location
Austria
Sponsor
Medical University Innsbruck
NCT06192342
Recruiting
Ventilatory Parameters in Acute Neurological Injury
Enrollment
19 pts
Location
Argentina
Sponsor
Ramos Mejía Hospital
NCT03065231
Recruiting
Lumbar Drain vs Extraventricular Drain to Prevent Vasospasm in Subarachnoid Hemorrhage
Enrollment
100 pts
Location
United States
Sponsor
University of California, San ...
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology